業績｜論文・出版物｜目次｜ALL

Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1

Nasimuzzaman, M., Kuroda, M., Dohno, S., Yamamoto, T., Iwatsuki, K., Matsuzaki, S., Rashel, M., Kumita, W., Mizuguchi, H., Hayakawa, T., Nakamura, H., Taguchi, T., Wakiguchi, H., Imai, S.

Mol. Ther., 11, 578-590 (2005)

PubMed

RNA interference of PPARγ using fiber-modified adenovirus vector efficiently suppresses preadipocyte-to-adipocyte differentiation in 3T3-L1 cells

Hosono T., Mizuguchi H., Katayama K., Koizumi N., Kawabata K., Yamaguchi T., Nakagawa S., Watanabe Y., Mayumi T., Hayakawa T.

Gene, 348, 157-165 (2005)

PubMed

A novel strategy for the enhancement of drug absorption using a claudin modulator

Kondoh, M., Masuyama , A., Takahashi, A., Asano, N., Mizuguchi H., Koizumi, N., Fujii, M., Hayakawa, T., Horiguchi, Y., Watanabe, Y.

Mol. Pharmacol., 67, 749-756 (2005)

PubMed

Gene therapy for human small cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference

Sumimoto H., Yamagata S., Shimizu A., Miyoshi H., Mizuguchi H., Hayakawa T., Miyagishi M., Taira K., Kawakami Y.

Gene Ther., 12, 95-100 (2005)

PubMed

Augmentation of the migratory ability of DC-based vaccine into regionalymph nodes by efficient CCR7 gene transduction

Okada N., Mori N., Koretomo R., Okada Y., Nakayama T., Yoshie O., Mizuguchi H., Hayakawa T., Nakagawa S., Mayumi T., Fujita T., Yamamoto A.

Gene Ther., 12, 129-139 (2005)

PubMed

Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12

Okada N., Iiyama S., Okada Y., Mizuguchi H., Hayakawa T., Nakagawa S., Mayumi T., Fujita T., Yamamoto A.

Cancer Gene Ther., 12, 72-83 (2005)

PubMed

Constitutively active PDX1 induced efficient insulin production in adult murine liver

Imai, J., Katagiri, H., Yamada, T., Ishigaki, Y., Ogihara, T., Uno, K., Hasegawa, Y., Gao, J., Ishihara, H., Sasano, H., Mizuguchi H., Asano, T., Oka, Y.

Biochem. Biophys. Res. Commun., 326, 402-409 (2005)

PubMed

Approaches to improving the kinetics of adenovirus-delivered genes and gene products

Xu ZL., Mizuguchi H., Koizumi N., Sakurai F., Hosono T., Kawabata K., Watanabe Y., Yamaguchi T., Hayakawa T.

Adv. Drug. Deli. Rev., 57, 781-802 (2005)

PubMed

Evaluation of immune response after administration of plasmid DNA-non-viral vector complexes

Sakurai F., Takakura Y., Hashida M.

Gene Design and Delivery, Springer, Non-viral Gene Therapy, 339-347 (2005)

WebSite

目的遺伝子の抑制レベルを自由に制御するアデノウイルスベクターの開発

水口裕之

実験医学, 羊土社, 23, 2167-2172 (2005)

WebSite

改良型アデノウイルスベクターを用いた造血幹細胞, 間葉系幹細胞, ES細胞への高効率遺伝子導入

水口裕之, 川端健二, 櫻井文教, 早川堯夫

炎症・再生, 25, 447-451 (2005)

J-STAGE

カプシドタンパク質を改変した改良型アデノウイルスベクターによる高効率遺伝子導入

水口裕之, 早川堯夫

BIO INDUSTRY, シーエムシー出版, 22, 16-21 (2005)

WebSite

ウイルスベクター

水口裕之, 早川堯夫

Drug Delivery System, 日本DDS学会, 20, 158-159 (2005)

CiNii

高性能な遺伝子導入ベクターの開発を目指して

櫻井文教

Drug Delivery System, 日本DDS学会, 20, 474-475 (2005)

CiNii

ウイルスベクターのＤＤＳ

水口裕之

Drug Metabolism and Pharmacokinetics, 19, 30-32 (2005)

CiNii

Targeted adenovirus vectors

Mizuguchi H., Hayakawa T.

Hum. Gene Ther., 15, 1034-1044 (2004)

PubMed

Adenovirus vector-mediated doxycycline-inducible RNA interference

Hosono T., Mizuguchi H., Katayama K., Xu ZL., Sakurai F., Ishii-Watabe A., Kawabata K., Yamaguchi T., Nakagawa S., Mayumi T., Hayakawa T.

Hum. Gene Ther., 15, 813-819 (2004)

PubMed

Efficient gene transfer into human trophoblast cells with adenovirus vector containing chimeric type 5 and 35 fiber protein

Koizumi, N., Mizuguchi H., Kondoh, M., Fujii, M., Hayakawa, T., Watanabe, Y.

Biol. Pharm. Bull., 27, 2046-2048 (2004)

PubMed

An improved method for detection of replication-competent retrovirus in retrovirus vector products

Uchida E., Sato K., Iwata A., Ishii-Watabe A., Mizuguchi H., Hikata M., Murata M., Yamaguchi T., Hayakawa T.

Biologicals, 32, 139-146 (2004)

PubMed

High gene expression of the mutant adenovirus vector, both in vitro and in vivo, with the insertion of integrin-targeting peptide into the fiber

Gao J-Q., Inoue S., Tsukada Y., Katayama K., Eto Y., Kurachi S., Mizuguchi H., Hayakawa T., Tsutsumi Y., Mayumi T., Nakagawa S.

Pharmazie, 59, 571-572 (2004)

PubMed

目次に戻る

大阪大学大学院薬学研究科分子生物学分野

Laboratory of Biochemistry and Molecular Biology

Graduate School of Pharmaceutical Sciences, Osaka University

業績｜論文・出版物｜目次｜ALL